• Je něco špatně v tomto záznamu ?

Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication

AK. Maniatis, M. Carakushansky, S. Galcheva, G. Prakasam, LA. Fox, A. Dankovcikova, J. Loftus, AA. Palladino, MLA. Resa, CT. Taylor, MT. Dattani, J. Lebl

. 2024 ; 15 (-) : 20420188241274363. [pub] 20241102

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002217

• For children with growth hormone deficiency, once-weekly somatrogon injections were less of a burden than once-daily somatropin injections. • The safety of weekly somatrogon was similar to that of daily somatropin. • Compared with daily somatropin injections, children with growth hormone deficiency may be less likely to miss weekly somatrogon injections. ○ This is because weekly somatrogon injections were less of a burden and were less likely to interfere with daily activities compared with daily somatropin injections. The purpose of this plain language summary is to help you to understand the findings from recent research. • Somatrogon is used to treat the condition under study that is discussed in this summary. Approval varies by country; please check with your local provider for more details. • The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study. This original scientific article on which this summary is based was published in the Journal of the Endocrine Society and can be accessed for free at: https://academic.oup.com/jes/article/6/10/bvac117/6695276. The details of the original article are as follows:Aristides K. Maniatis, Mauri Carakushansky, Sonya Galcheva, Gnanagurudasan Prakasam, Larry A. Fox, Adriana Dankovcikova, Jane Loftus, Andrew A. Palladino, Maria de los Angeles Resa, Carrie Turich Taylor, Mehul T. Dattani, Jan Lebl. Treatment burden of weekly somatrogon versus daily somatropin in children with growth hormone deficiency: a randomized study. J Endocr Soc 2022; 6(10): bvac117. DOI: 10.1210/jendso/bvac117.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002217
003      
CZ-PrNML
005      
20250123102017.0
007      
ta
008      
250117e20241102xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/20420188241274363 $2 doi
035    __
$a (PubMed)39493411
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Maniatis, Aristides K $u Rocky Mountain Pediatric Endocrinology, Centennial, CO, USA
245    10
$a Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication / $c AK. Maniatis, M. Carakushansky, S. Galcheva, G. Prakasam, LA. Fox, A. Dankovcikova, J. Loftus, AA. Palladino, MLA. Resa, CT. Taylor, MT. Dattani, J. Lebl
520    9_
$a • For children with growth hormone deficiency, once-weekly somatrogon injections were less of a burden than once-daily somatropin injections. • The safety of weekly somatrogon was similar to that of daily somatropin. • Compared with daily somatropin injections, children with growth hormone deficiency may be less likely to miss weekly somatrogon injections. ○ This is because weekly somatrogon injections were less of a burden and were less likely to interfere with daily activities compared with daily somatropin injections. The purpose of this plain language summary is to help you to understand the findings from recent research. • Somatrogon is used to treat the condition under study that is discussed in this summary. Approval varies by country; please check with your local provider for more details. • The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study. This original scientific article on which this summary is based was published in the Journal of the Endocrine Society and can be accessed for free at: https://academic.oup.com/jes/article/6/10/bvac117/6695276. The details of the original article are as follows:Aristides K. Maniatis, Mauri Carakushansky, Sonya Galcheva, Gnanagurudasan Prakasam, Larry A. Fox, Adriana Dankovcikova, Jane Loftus, Andrew A. Palladino, Maria de los Angeles Resa, Carrie Turich Taylor, Mehul T. Dattani, Jan Lebl. Treatment burden of weekly somatrogon versus daily somatropin in children with growth hormone deficiency: a randomized study. J Endocr Soc 2022; 6(10): bvac117. DOI: 10.1210/jendso/bvac117.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Carakushansky, Mauri $u Nemours Children's Hospital, Orlando, FL, USA
700    1_
$a Galcheva, Sonya $u UMHAT "St. Marina", Varna, Bulgaria
700    1_
$a Prakasam, Gnanagurudasan $u Sutter Medical Center and Center of Excellence in Diabetes and Endocrinology, Sacramento, CA, USA
700    1_
$a Fox, Larry A $u Nemours Children's Health System, Jacksonville, FL, USA
700    1_
$a Dankovcikova, Adriana $u Children's Faculty Hospital Košice, Košice, Slovakia
700    1_
$a Loftus, Jane $u Pfizer Ltd, Tadworth, UK
700    1_
$a Palladino, Andrew A $u Pfizer inc, Collegeville PA, USA
700    1_
$a Resa, Maria de Los Angeles $u Pfizer Inc, New York, NY, USA
700    1_
$a Taylor, Carrie Turich $u Pfizer Inc, New York, NY, USA
700    1_
$a Dattani, Mehul T $u UCL Great Ormond Street Institute of Child Health, London, UK
700    1_
$a Lebl, Jan $u Charles University Second Faculty of Medicine, Praha, Czech Republic
773    0_
$w MED00176783 $t Therapeutic advances in endocrinology and metabolism $x 2042-0188 $g Roč. 15 (20241102), s. 20420188241274363
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39493411 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123102011 $b ABA008
999    __
$a ok $b bmc $g 2254504 $s 1238220
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 20420188241274363 $e 20241102 $i 2042-0188 $m Therapeutic advances in endocrinology and metabolism $n Ther Adv Endocrinol Metab $x MED00176783
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Možnosti archivace